Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thu, 04/17/14 - 11:49 am
Tags:
Sovaldi, hepatitis C, Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, Express Scripts
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
Tags:
MannKind, Alkermes, Gilead Sciences, ledipasvir, AbbVie, Afrezza, aripiprazole lauroxil, Pharmacyclics, Imbruvica
AbbVie initiates Phase III clinical trial of veliparib in lung cancer
The Fly on the Wall
Tue, 04/15/14 - 10:09 am
Tags:
AbbVie, clinical trials, veliparib, non-small cell lung cancer
AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress
Yahoo/PR NewsWire
Sat, 04/12/14 - 10:15 am
Tags:
hepatitis, hepatitis C, AbbVie, Ribavirin
Doctors welcome hepatitis C drug rivals, Gilead still leads
Yahoo/Reuters
Fri, 04/11/14 - 08:47 am
Tags:
physicians, hepatitis C, Gilead Sciences, Sovaldi, Merck, AbbVie, Bristol-Myers Squibb
AbbVie Drops EU Court Bid to Block Clinical-Trial Data Release
Bloomberg
Thu, 04/3/14 - 05:50 pm
Tags:
clinical trial data, Europe, AbbVie
U.S. wants at least $1 billion from drugmakers who delay generics
Yahoo/Reuters
Fri, 03/28/14 - 12:59 pm
Tags:
generics, pay-for-delay, FTC, Solvay, AbbVie, Actavis, Perrigo Company, Par Pharmaceutical, Teva, Cephalon
Can AbbVie's Legacy Products Deliver Further Growth?
Motley Fool
Fri, 03/28/14 - 08:26 am
Tags:
Pancreatic enzyme products, AbbVie, Synthroid, Duodopa
Watch Out AbbVie, Here Comes Celgene
Motley Fool
Wed, 03/26/14 - 12:45 pm
Tags:
Celgene, AbbVie, Humira, Stelara, Otezla
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
Tags:
AbbVie, Amgen, Gilead Sciences, Achillion, Alexion, Ariad Pharmaceuticals, Pharmacyclics, Seattle Genetics
AbbVie CEO's pay doubles to $18.2M in Abbott pharma spinoff's first solo year
Fierce Pharma
Tue, 03/25/14 - 09:54 am
Tags:
AbbVie, Pharma CEOs, executive pay, Richard Gonzalez
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
Tags:
hepatitis C, Sovaldi, Gilead Sciences, daclatasvir, Bristol-Myers Squibb, AbbVie, Enanta Pharmaceuticals
Can AbbVie Continue Its Bull Run?
Motley Fool
Sat, 03/15/14 - 10:13 am
Tags:
AbbVie
[video]This Small Biotech Will Profit From the Hep C Drug Race
Motley Fool
Fri, 03/14/14 - 08:41 am
Tags:
biotech, Enanta Pharmaceuticals, hepatitis C, Gilead Sciences, AbbVie
With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales
Fierce Pharma
Tue, 03/11/14 - 12:00 pm
Tags:
Sovaldi, FDA, Gilead Sciences, Novo Nordisk, AbbVie, Biogen Idec
FirstWord Lists – Pharma's 50 biggest selling drugs: AbbVie's Humira joins the $10 billion club
First Word Pharma
Mon, 03/10/14 - 11:56 am
Tags:
prescription data, Humira, AbbVie
AbbVie's Humira Still a Growth Engine
Motley Fool
Sun, 03/9/14 - 01:35 pm
Tags:
AbbVie, Humira, rheumatoid arthritis, psoriasis
Can Merck Outperform AbbVie and Eli Lilly in 2014?
Motley Fool
Thu, 03/6/14 - 11:36 am
Tags:
AbbVie, Eli Lilly, Merck
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Tue, 03/4/14 - 12:31 pm
Tags:
Dendreon, AbbVie, Omeros, Provenge, prostate cancer, ABT-450, hepatitis C, OMS721
AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
Tags:
AbbVie, hepatitis C, ABT-450, ABT-267, ABT-333, Gilead Sciences, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.